PATENT CLAIM ANALYSIS

Application Number: 16099673
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "211130"]

Abstract:
Alcoholism, and symptoms and negative effects thereof may be treated using ibudilast or a pharmaceutically acceptable salt thereof. Patients diagnosed with alcohol use disorder and who exhibit symptoms of depression and/or dysphoric mood can be treated using ibudilast or a pharmaceutically acceptable salt thereof.

Claim (Index 1):
A method of treating a patient diagnosed with alcohol use disorder (AUD) comprising administering to a patient diagnosed with AUD a therapeutically effective amount of ibudilast or a pharmaceutically acceptable salt thereof, in which the patient also exhibits symptoms of depression or dysphoric mood.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.46875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15851066', '14188061', '15527280', '11527757', '11295730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7586541996111509
- 35 USC 102 Novelty (BERT): 0.5139499831558006
- Combined Prediction Score: 0.7341837779656158
- Mean Citation Score: 247.868772
- Max Citation Score: 307.0052
- Similarity Product: 234.5566385894776

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test